Confirmed Speakers Include:

Gregg Alton, Executive Vice President, Gilead Sciences, Foster City

Jana Armstrong, Executive Director, Drugs for Neglected Disease Initiative, New York

Brook Baker, Professor of Law, Northeastern University

Steve Carlson, Fish & Richardson PC, Silicon Valley

Philip Chase, Vice President, Legal, Alnylam Pharmaceuticals, Cambridge

Dr. Richard Chin, CEO, Institute for One World Health, San Francisco

Suzanne Drennon Munck, FTC Bureau of Competition, Office of Policy and Coordination, Washington

Ellen ‘t Hoen, Senior Adviser on Intellectual Property and Medicines Patent Pool, UNITAID, Geneva

Amy Kapczynski, Berkeley Law

Sherry Knowles, Senior Vice President, Corporate IP, GlaxoSmithKline, New York

Cale Lennon, Ph.D, Assistant Director, Technology Transfer Office, Emory University, Atlanta

Jamie Love, Director, Knowledge Ecology International, Washington, D.C.

Emi MacLean, Doctors Without Borders, New York

Kathleen McCowin,  IP and Industry Research Alliences, UC Berkeley

Dr. Carol Mimura, Assistant Vice Chancellor for IP and Industry Research Alliances, UC Berkeley

Vern Norviel, Life Sciences IP, Licensing, and Transactions, Wilson Sonsini Goodrich & Rosati, Palo Alto

Roger Ross, General Counsel, Via Licensing, San Francisco

Robert Sachs, Fenwick & West

Suzanne Scotchmer, Professor of Law, Economics, and Public Policy, UC Berkeley

Dr. Anthony So, Director, Program on Global Health and Technology Access, Duke University, Durham

David Winickoff, Professor of Bioethics and Society, UC Berkeley